J&J Precise Panel Vote Nearly Split On Carotid Disease Subgroup Benefit

Carotid revascularization with Cordis' Precise stent is a safe alternative to surgery for high-risk patients, although its benefit to asymptomatic patients remains unclear, an FDA panel concluded April 21

More from Archive

More from Medtech Insight